Whole-Body Cryotherapy (WBC) as an Adjunct Treatment on Pain in Fibromyalgia Persons: Short Time Effect.

March 8, 2018 updated by: François Tubez, Haute École Robert Schuman Libramont
Our aim was to determine whether Whole Body Cryotherapy (WBC) can result in improved pain status, perceived health, and quality of life in patients with fibromyalgia. It is hypothesized that this positive effect can be achieved through increased functional mobility and decreased pain intensity resulting from cold-induced modulation of the inflammation-immune axis.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

24 patients with fibromyalgia were randomized into 2 groups (n=11 in the WBC group, n=13 in the control group). In the WBC group, 10 sessions of WBC were performed (in addition to usual care) in a standard cryotherapy room over a duration of 8 days. Patients in the control group did not change anything in their everyday activities. Several self-reported variables relating to perceived health were measured repeatedly (pain intensity, functional mobility, and quality of life).

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Fibromyalgia diagnosis

Exclusion Criteria:

cardiorespiratory disorder current pregnancy cold intolerance Embolic diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Whole body cryotherapy arm
intervention consisted of 10 sessions of WBC (three minutes for each session) which were performed in addition to usual care in a standard cryotherapy room over a duration of 8 days.
10 sessions of WBC were performed (in addition to usual care) in a standard cryotherapy room over a duration of 8 days.
Other Names:
  • Usual intervention
No Intervention: Usual treatment arm
usual care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain status at 1 month from baseline
Time Frame: change from baseline at one month follow-ups
pain score on a numerical scale (Subjective Numerical scale) likert rating 0 to 10 by the fibromyalgia patient 0 indicate no pain, 10 maximal pain value
change from baseline at one month follow-ups

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain status at 2 weeks from baseline
Time Frame: change from baseline at two weeks follow-ups
pain score on a Subjective Numerical scale 0 to 10; likert rating 0 to 10 by the fibromyalgia patient 0 indicate no pain, 10 maximal pain value
change from baseline at two weeks follow-ups
functional status : the Oswestry Disability Index (ODI), subjective low back pain questionnaire
Time Frame: chnage from baseline at two weeks follow-ups

Patient-completed questionnaire which gives a subjective percentage score of level of function (disability) in activities of daily living in those rehabilitating from low back pain There are 10 questions (items). The questions are designed in a way that to realize how the back or leg pain is affecting the patient's ability to manage in everyday life.

Each of the 10 items is scored from 0 - 5. The maximum score is therefore 50. The obtained score can be multiplied by 2 to produce a percentage score.

If the first statement is marked, the section score = 0, If the last statement is marked, it = 5

If all ten sections are completed the score is calculated as followed:

Example: 10 (total score of the patient), 50 (total possible raw score), 10/50 x 100 = 20%

If one section is missed or not applicable, the score is calculated as followed:

Example: 15 (total score of the patient), 45 (total possible score), 15/45 x 100 = 30%

chnage from baseline at two weeks follow-ups
functional status : the Oswestry Disability Index (ODI)
Time Frame: change from baseline at one month follow-ups

Patient-completed questionnaire which gives a subjective percentage score of level of function (disability) in activities of daily living in those rehabilitating from low back pain There are 10 questions (items). The questions are designed in a way that to realize how the back or leg pain is affecting the patient's ability to manage in everyday life.

Each of the 10 items is scored from 0 - 5. The maximum score is therefore 50. The obtained score can be multiplied by 2 to produce a percentage score.

If the first statement is marked, the section score = 0, If the last statement is marked, it = 5

If all ten sections are completed the score is calculated as followed:

Example: 10 (total score of the patient), 50 (total possible raw score), 10/50 x 100 = 20%

If one section is missed or not applicable, the score is calculated as followed:

Example: 15 (total score of the patient), 45 (total possible score), 15/45 x 100 = 30%

change from baseline at one month follow-ups
functional status : the Disability of the Arm, Shoulder and Hand (DASH) score
Time Frame: change from baseline at one month follow-ups
The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities. This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale. DASH Scoring Formula = ([(sum of n responses)/n] -1)(25) where n represents the number of completed items. The score on both test ranges from 0 (no disability) to 100 (most severe disability).Minimal Detectable Change (MDC) is between 12.75% - 17.23%
change from baseline at one month follow-ups
functional status : Lower Extremity Functional Scale (LEFS)
Time Frame: change from baseline at one month follow-ups
The test can be used to evaluate the impairment of a patient with lower extremity musculoskeletal condition or disorders. Can be used clinically to measure the patients' initial function, ongoing progress, and outcome as well as to set functional goals.In 1999, Binkley et al. developed the Lower Extremity Functional Scale (LEFS), a patient-reported lower limb function questionnaire applicable to a wide spectrum of outpatients with a lower limb musculoskeletal condition. The LEFS consists of 20 items, each scored on a 5-point scale (0 to 4). The total score varies from 0 to 80, with higher scores representing better a functional status.
change from baseline at one month follow-ups
health related quality of life (HRQoL)
Time Frame: change from baseline to one month follow-ups
physical functioning (PCS) and mental functioning (MCS) from the SF-36 questionnaire The score on both test ranges from 0 (poor health related quality of life) to 100 (better health related quality of life value)
change from baseline to one month follow-ups

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: guillaume polidori, Pr, University of Reims

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

April 1, 2017

Study Completion (Actual)

May 30, 2017

Study Registration Dates

First Submitted

February 2, 2018

First Submitted That Met QC Criteria

March 8, 2018

First Posted (Actual)

March 15, 2018

Study Record Updates

Last Update Posted (Actual)

March 15, 2018

Last Update Submitted That Met QC Criteria

March 8, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

confidential personal data

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fibromyalgia

Clinical Trials on Whole-Body Cryotherapy

3
Subscribe